阿奇霉素联合特步他林雾化吸入治疗小儿支原体肺炎的临床疗效  

Efficacy of azithromycinunite combined with terbutaline aerosol inhalation treatment in pediatric mycoplasma pneumonia

作　　者：吴伟波 陈倩[2] 

机构地区：[1]温岭市第一人民医院药剂科,浙江台州317500 [2]温州医学院药学院,浙江温州325035

出　　处：《中国临床药理学杂志》2014年第6期475-477,共3页The Chinese Journal of Clinical Pharmacology

摘　　要：目的评价阿奇霉素联合特步他林雾化治疗小儿支原体肺炎的临床疗效。方法小儿支原体肺炎患儿78例随机分为2组,治疗组用阿奇霉素联合特步他林雾化吸入治疗,对照组用红霉素联合小儿咳喘灵口服液治疗,疗程均为7 d,观察治疗前后的疗效和临床体征。结果治疗组临床症状消失时间及胸片恢复时间较对照组显著缩短;治疗组总有效率为94.87%;对照组总有效率为87.18%,治疗组疗效优于对照组(P<0.05)。结论阿奇霉素联合特步他林雾化吸入治疗小儿支原体肺炎安全,有效。Objective To investigate the efficacy of azithromycinunite combined with terbutaline aerosol inhalation treament in pediatric mycoplasma pneumonia. Methods Seventy eight cases of pediatric mycoplasma pneumonia were randomly divided into two groups. The treatment group was treated with azithromycin plus terhutaline inhalation, the control group with erythromycin plus pediatric cough oral liquid treatment, both treatments were adopted for seven days. And the effects and signs of symptoms were observed before and after treatment, respectively. Results Compared with control group, the disappearing time of clinical symp- toms and chest recovery time were significantly reduced in a shorter time. The total effective in treatment group was 94. 87%, and 87. 18% in the control group, the curative effect of the treatment group was better than the control group （P 〈 0. 05）. Conclusion Azithromycin plus terbutaline inhalation treatment for pediatric mycoplasma pneumonia is safe and effective.

关 键 词：小儿支原体肺炎 阿奇霉素 特步他林 小儿咳喘灵口服液 红霉素 

分 类 号：R978.1[医药卫生—药品] R725.6[医药卫生—药学]